Steve Allen, Tackle Patient Representative, reports that the combined application for appeal against the NICE decision on Abiraterone made by Tackle and Prostate Cancer UK has been successful.
A submission made by Prof Nick James, a nominated clinical expert, has also been accepted.
This is merely a first step in a long process. It does in no way mean the original decision will be revoked but at least it is progress.
